Mangoceuticals, Inc. (MGRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 212.47K | 1.55M | 598.22K | 117.96K | 176.65K | 75.59K | 104.07K | 517.56K | 89.81K | 818.46K | 1.34M | 3.02M |
| Cash & Short-Term Investments | 174.56K | 1.49M | 481.28K | 101.02K | 76.5K | 58.65K | 73.91K | 490.24K | 15.3K | 739.01K | 1.24M | 2.95M |
| Cash Only | 174.56K | 1.49M | 481.28K | 101.02K | 76.5K | 58.65K | 73.91K | 490.24K | 15.3K | 739.01K | 1.24M | 2.95M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 20.06K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 26.6 | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 13.21K | 14.02K | 14.45K | 18.5K | 21.58K | 23.49K |
| Days Inventory Outstanding | - | - | - | - | - | - | 24.71 | 13.87 | 22.48 | 18.11 | 20.62 | 39.51 |
| Other Current Assets | 0 | 61.1K | 116.94K | 0 | 100.16K | 0 | 16.94K | 13.3K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 14.24M | 14.54M | 15.93M | 20.72M | 21.58M | 15.29M | 14.69M | 14.72M | 211.64K | 232.33K | 252.79K | 272.81K |
| Property, Plant & Equipment | 295.61K | 309.65K | 13.26K | 29.97K | 46.33K | 62.3K | 77.97K | 213.14K | 194.7K | 215.39K | 235.85K | 255.87K |
| Fixed Asset Turnover | 0.22x | 0.58x | 3.90x | 4.41x | 2.01x | 1.50x | 0.92x | 0.80x | 1.04x | 1.08x | 1.00x | 0.53x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 13.94M | 14.23M | 15.92M | 20.69M | 21.53M | 15.23M | 14.61M | 14.61M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 250K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | -250K | -102.88K | 16.94K | 16.94K | 16.94K | 16.94K |
| Total Assets | 14.45M | 16.09M | 16.53M | 20.84M | 21.75M | 15.37M | 14.79M | 15.24M | 301.45K | 1.05M | 1.6M | 3.3M |
| Asset Turnover | 0.00x | 0.01x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.32x | 0.18x | 0.10x | 0.04x |
| Asset Growth % | -33.58% | 4.68% | 11.76% | 36.78% | 7116.48% | 1362.75% | 827.11% | 362.23% | -92.67% | 4.74% | 74.61% | 379688.25% |
| Total Current Liabilities | 737.61K | 890.57K | 804.27K | 1.6M | 1.5M | 1.43M | 1.39M | 1.38M | 1.21M | 211.08K | 159.18K | 196.48K |
| Accounts Payable | 529.8K | 0 | 0 | 768K | 1.18M | 837.5K | 753.96K | 718.65K | 1.05M | 140.76K | 89.06K | 130.2K |
| Days Payables Outstanding | 1.23K | - | - | 1.13K | 1.92K | 2.91K | 1.34K | 862.33 | 812.97 | 103.86 | 100.29 | 135.39 |
| Short-Term Debt | 0 | 307.82K | 212.17K | 600K | 0 | 150K | 187.5K | 187.5K | 87.5K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 150.75K | 582.75K | 592.11K | 0 | 277.3K | 373K | 375K | 400K | 0 | 0 | 8.2K | 0 |
| Current Ratio | 0.29x | 1.74x | 0.74x | 0.07x | 0.12x | 0.05x | 0.07x | 0.38x | 0.07x | 3.88x | 8.44x | 15.39x |
| Quick Ratio | 0.29x | 1.74x | 0.74x | 0.07x | 0.12x | 0.05x | 0.07x | 0.37x | 0.06x | 3.79x | 8.30x | 15.27x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 236.97K | 0 | 0 | 0 | 0 | 0 | 12.17K | 30.12K | 47.71K | 64.96K | 81.51K | 97.39K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 236.97K | 0 | 0 | 0 | 0 | 0 | 12.17K | 30.12K | 47.71K | 64.96K | 81.51K | 97.39K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Total Liabilities | 974.57K | 890.57K | 804.27K | 1.6M | 1.5M | 1.43M | 1.4M | 1.41M | 1.26M | 276.04K | 240.68K | 293.87K |
| Total Debt | 294.02K | 307.82K | 212.17K | 630.12K | 47.71K | 214.96K | 269.01K | 285.05K | 200.77K | 128.68K | 143.43K | 157.54K |
| Net Debt | 119.46K | -1.18M | -269.11K | 529.1K | -28.78K | 156.31K | 195.09K | -205.2K | 185.46K | -610.33K | -1.09M | -2.79M |
| Debt / Equity | 0.02x | 0.02x | 0.01x | 0.03x | 0.00x | 0.02x | 0.02x | 0.02x | - | 0.17x | 0.11x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -12.29x | -139.84x | -99.45x | -248.58x | - | -5.32x | -7.28x | -9.74x | - | -346.45x | - | - |
| Total Equity | 13.47M | 15.2M | 15.73M | 19.24M | 20.25M | 13.95M | 13.39M | 13.83M | -958.47K | 774.75K | 1.35M | 3M |
| Equity Growth % | -33.46% | 8.99% | 17.47% | 39.14% | 2212.82% | 1699.93% | 888.21% | 360.57% | -125.1% | 26.18% | 64.45% | 2270.64% |
| Book Value per Share | 1.34 | 1.51 | 1.36 | 1.93 | 4.41 | 4.30 | 6.65 | 7.95 | -0.63 | 0.60 | 1.28 | 2.69 |
| Total Shareholders' Equity | 13.48M | 15.2M | 15.73M | 19.24M | 20.25M | 13.95M | 13.39M | 13.83M | -958.43K | 774.75K | 1.35M | 3M |
| Common Stock | 1.7K | 1.59K | 1.39K | 1.06K | 715 | 325 | 213 | 2.91K | 2.36K | 2.14K | 1.68K | 1.67K |
| Retained Earnings | -44.05M | -40.65M | -37.88M | -31.65M | -25.94M | -20.81M | -17.99M | -15.99M | -13.6M | -11.23M | -8.66M | -6.86M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -3.19K | -2.76K | -2.08K | -2.03K | -2.22K | -9.85K | -1.66K | -486.67K | -70 | 0 | 0 | 0 |
| Minority Interest | -1.53K | -1.54K | -1.74K | -1.18K | -1.18K | -1.08K | -837 | -376 | -36 | 0 | 0 | 0 |